Last updated on June 2020

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice


Brief description of study

This is an observational, multicenter study in patients treated with nivolumab for the approved indications of melanoma and lung cancer in Australia, the EU, Switzerland, and the United States (US). Targeted countries in the EU for study participation include Austria, Belgium, France, Germany, Italy, Spain, and the United Kingdom (UK). Study objectives are to assess the safety experience, survival, adverse event management, and outcomes of adverse events associated with nivolumab in routine oncology care facilities.

Detailed Study Description

This is an observational, multicenter study in patients treated with nivolumab for the approved indications of melanoma and lung cancer in Australia, the EU, Switzerland, and the United States (US). Targeted countries in the EU for study participation include Austria, Belgium, France, Germany, Italy, Spain, and the United Kingdom (UK). Study objectives are to assess the safety experience, survival, adverse event management, and outcomes of adverse events associated with nivolumab in routine oncology care facilities. The study will be started in 2016, and data collection will be continued until March 2024.

Clinical Study Identifier: NCT02847728

Find a site near you

Start Over

Local Institution

Houston, TX United States
  Connect »

Local Institution

LaGrange, GA United States
  Connect »

Local Institution

Locarno, Switzerland
  Connect »

Local Institution

Ludwigshafen, Germany
  Connect »

Oncology Specialists

Niles, IL United States
  Connect »

St. Joseph's/Candler SC Cancer Specialist

Hilton Head Island, SC United States
  Connect »

Local Institution

Bristol, United Kingdom
  Connect »

Local Institution

Traunstein, Germany
  Connect »

Local Institution

Regensburg, Germany
  Connect »

Local Institution

Sant'Andrea delle Fratte, Italy
  Connect »

Local Institution

Recklinghausen, Germany
  Connect »

Local Institution

Wagga Wagga, Australia
  Connect »

Local Institution

Quedlinburg, Germany
  Connect »

Local Institution

Cornwall, United Kingdom
  Connect »

Local Institution

Germantown, TN United States
  Connect »

Local Institution

Greifswald, Germany
  Connect »

Local Institution

Saarbruecken, Germany
  Connect »

Local Institution

Vandoeuvre-les-Nancy Cedex, France
  Connect »

Local Institution

Lerchenfeld, Germany
  Connect »

Local Institution

Heidelberg, Germany
  Connect »

Ellis Fischel Cancer Center

Columbia, MO United States
  Connect »

Lake City Cancer Care, LLC

Lake City, FL United States
  Connect »

21st Century Oncology

Jacksonville, FL United States
  Connect »

Local Institution

Saint-Priest en Jarez, France
  Connect »

Local Institution

Palm Springs, CA United States
  Connect »

Oncology Specialists

Park Ridge, IL United States
  Connect »

Local Institution

Brasschaat, Belgium
  Connect »

Local Institution

Sant'Andrea Delle Fratte, Italy
  Connect »

Local Institution

Aberdeen, United Kingdom
  Connect »

Local Institution

Frankston, Australia
  Connect »

Local Institution

Klagenfurt, Austria
  Connect »

Local Institution

Ballenstedt, Germany
  Connect »

Local Institution

Bremerhaven, Germany
  Connect »

Local Institution

Glasgow, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.